OpenAlex
Benzylguanidine and Galactose Double-Conjugated Chitosan Nanoparticles with Reduction Responsiveness for Targeted Delivery of Doxorubicin to CXCR 4 Positive Tumors
Work
Year: 2020
Type: article
Cites: 35
Cited by: 14
Related to: 10
FWCI: 0.81
Citation percentile (by year/subfield): 48.84
Subfield: Biomaterials
Sustainable Development Goal Good health and well-being
Open Access status: closed
Grant IDS 81573356, 81673371